194 related articles for article (PubMed ID: 37001292)
1. Precise profiling of exosomal biomarkers via programmable curved plasmonic nanoarchitecture-based biosensor for clinical diagnosis of Alzheimer's disease.
Song S; Lee JU; Jeon MJ; Kim S; Lee CN; Sim SJ
Biosens Bioelectron; 2023 Jun; 230():115269. PubMed ID: 37001292
[TBL] [Abstract][Full Text] [Related]
2. Detection of multiplex exosomal miRNAs for clinically accurate diagnosis of Alzheimer's disease using label-free plasmonic biosensor based on DNA-Assembled advanced plasmonic architecture.
Song S; Lee JU; Jeon MJ; Kim S; Sim SJ
Biosens Bioelectron; 2022 Mar; 199():113864. PubMed ID: 34890883
[TBL] [Abstract][Full Text] [Related]
3. Distinct plasma phosphorylated-tau proteins profiling for the differential diagnosis of mild cognitive impairment and Alzheimer's disease by plasmonic asymmetric nanobridge-based biosensor.
Kim S; Ma X; Jeon MJ; Song S; Lee JS; Lee JU; Lee CN; Choi SH; Sim SJ
Biosens Bioelectron; 2024 Apr; 250():116085. PubMed ID: 38295582
[TBL] [Abstract][Full Text] [Related]
4. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
5. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease.
Van Giau V; An SS
J Neurol Sci; 2016 Jan; 360():141-52. PubMed ID: 26723991
[TBL] [Abstract][Full Text] [Related]
6. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
7. Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer's disease and mild cognitive impairment.
Liu W; Lin H; He X; Chen L; Dai Y; Jia W; Xue X; Tao J; Chen L
Transl Psychiatry; 2020 Apr; 10(1):125. PubMed ID: 32350238
[TBL] [Abstract][Full Text] [Related]
8. A Nanoplasmonic Biosensor for Ultrasensitive Detection of Alzheimer's Disease Biomarker Using a Chaotropic Agent.
Kim H; Lee JU; Kim S; Song S; Sim SJ
ACS Sens; 2019 Mar; 4(3):595-602. PubMed ID: 30747516
[TBL] [Abstract][Full Text] [Related]
9. Circulating MicroRNAs as Diagnostic Biomarkers of Clinical Cognitive Impairment: A Meta-Analysis.
Shi D; Han M; Liu W; Tao J; Chen L
Am J Alzheimers Dis Other Demen; 2020; 35():1533317520951686. PubMed ID: 33094634
[TBL] [Abstract][Full Text] [Related]
10. A shape-code nanoplasmonic biosensor for multiplex detection of Alzheimer's disease biomarkers.
Kim H; Lee JU; Song S; Kim S; Sim SJ
Biosens Bioelectron; 2018 Mar; 101():96-102. PubMed ID: 29054022
[TBL] [Abstract][Full Text] [Related]
11. Surface plasmon resonance biosensors for detection of Alzheimer's biomarkers; an effective step in early and accurate diagnosis.
Rezabakhsh A; Rahbarghazi R; Fathi F
Biosens Bioelectron; 2020 Nov; 167():112511. PubMed ID: 32858422
[TBL] [Abstract][Full Text] [Related]
12. Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment.
Cheng L; Doecke JD; Sharples RA; Villemagne VL; Fowler CJ; Rembach A; Martins RN; Rowe CC; Macaulay SL; Masters CL; Hill AF;
Mol Psychiatry; 2015 Oct; 20(10):1188-96. PubMed ID: 25349172
[TBL] [Abstract][Full Text] [Related]
13. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Diagnostic Performances Between Cerebrospinal Fluid Biomarkers and Amyloid PET in a Clinical Setting.
Jung NY; Kim ES; Kim HS; Jeon S; Lee MJ; Pak K; Lee JH; Lee YM; Lee K; Shin JH; Ko JK; Lee JM; Yoon JA; Hwang C; Choi KU; Lee EC; Seong JK; Huh GY; Kim DS; Kim EJ
J Alzheimers Dis; 2020; 74(2):473-490. PubMed ID: 32039853
[TBL] [Abstract][Full Text] [Related]
15. The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer's Disease Biomarkers.
Yang TT; Liu CG; Gao SC; Zhang Y; Wang PC
Biomed Environ Sci; 2018 Feb; 31(2):87-96. PubMed ID: 29606187
[TBL] [Abstract][Full Text] [Related]
16. Quantitative and Specific Detection of Exosomal miRNAs for Accurate Diagnosis of Breast Cancer Using a Surface-Enhanced Raman Scattering Sensor Based on Plasmonic Head-Flocked Gold Nanopillars.
Lee JU; Kim WH; Lee HS; Park KH; Sim SJ
Small; 2019 Apr; 15(17):e1804968. PubMed ID: 30828996
[TBL] [Abstract][Full Text] [Related]
17. CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer's disease.
Teuber-Hanselmann S; Rekowski J; Vogelgsang J; von Arnim C; Reetz K; Stang A; Jöckel KH; Wiltfang J; Esselmann H; Otto M; Tumani H; Herring A; Keyvani K
J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):40-48. PubMed ID: 31371645
[TBL] [Abstract][Full Text] [Related]
18. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
[TBL] [Abstract][Full Text] [Related]
19. Exosome-encapsulated microRNAs as promising biomarkers for Alzheimer's disease.
Chen JJ; Yang G; Yan QQ; Zhao J; Li S
Rev Neurosci; 2019 Dec; 31(1):77-87. PubMed ID: 31318699
[TBL] [Abstract][Full Text] [Related]
20. An electrochemical peptide-based biosensor for the Alzheimer biomarker amyloid-β
Negahdary M; Heli H
Mikrochim Acta; 2019 Nov; 186(12):766. PubMed ID: 31713687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
